Skip to main content

Xenon Pharmaceuticals Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.

Current Price

$54.12

-1.02%
Profile
Valuation (TTM)
Market Cap$4.50B
P/E-11.75
EV
P/B7.74
Shares Out83.19M
P/Sales
Revenue$0.00
EV/EBITDA

Xenon Pharmaceuticals Inc (XENE) Social Sentiment

XENE Social Sentiment Analysis

Social media sentiment analysis for Xenon Pharmaceuticals Inc (XENE). Track bullish and bearish sentiment, mention volume, and BuzzScore trends from StockTwits and Reddit. Social sentiment provides a crowd-sourced view of investor confidence in XENE.

Current stock price: $54.12. Market cap: $4.50B. This page displays sentiment timelines, bullish vs bearish ratios, total mention counts, peak BuzzScore data, and source breakdowns for XENE. The sentiment data is updated regularly to reflect the latest social media activity.

Social sentiment is one of many signals to consider when evaluating a stock. High bullish sentiment combined with strong fundamentals may reinforce a buy thesis. Use GoodMoat's sentiment tracking alongside quality analysis, financial data, and valuation models to make well-informed investment decisions about Xenon Pharmaceuticals Inc.